Banco de Sabadell’s Celgene Corp CELG Stock Holding History

Banco de Sabadell’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-250	Closed	-$23K	–	406
2019 Q1	$23K	Buy	+250	New	+$21.9K	﹤0.01%	334
2018 Q4	–	Sell	-11,000	Closed	-$983K	–	477
2018 Q3	$983K	Sell	11,000 -700	-6%	-$61.9K	0.11%	190
2018 Q2	$913K	Buy	11,700 +700	+6%	+$58.1K	0.12%	186
2018 Q1	$958K	Hold	11,000	–	–	0.12%	197
2017 Q4	$1.15M	Buy	+11,000	New	+$1.24M	0.15%	146

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Banco de Sabadell's CELG Position: Q2 2019 in Review

Banco de Sabadell sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 250 shares — an estimated $23K sold.

Banco de Sabadell first reported a position in CELG in Q4 2017 and held it in 5 quarters. The position peaked at $1.15M in Q4 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Banco de Sabadell reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Banco de Sabadell sold 250 Celgene Corp shares in Q2 2019, an estimated $23K.
Banco de Sabadell first reported a position in Celgene Corp in Q4 2017 and held it in 5 quarters.
Banco de Sabadell's Celgene Corp position peaked at $1.15M in Q4 2017.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Banco de Sabadell's 13F filing for Q2 2019, filed 13 Aug 2019.